|
|
| Line 6: |
Line 6: |
|
| |
|
| **Alzheimer’s Disease | | **Alzheimer’s Disease |
| ***[[Acetylcholine]] | | ***See: [[Alzheimer's Disease]] |
| ***[[Acetylcholinesterase]]
| |
| ***[[2ace|Acetylcholinesterase from Torpedo Californica]]
| |
| ***[[African Malaria Mosquito Acetylcholinesterase]]
| |
| ***[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]]
| |
| ***[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]]
| |
| ***[[Beta Amyloid]]
| |
| ***[[Acetylcholine binding protein]] (AChBP)
| |
| ***[[Butyrylcholinesterase]] (BChE)
| |
| ***Drug Compounds & Substrates
| |
| ****[[AChE_bivalent_inhibitors|Bivalent Inhibitors of Acetylcholinesterase]]
| |
| ****[[AChE_bivalent_inhibitors_%28Part_II%29|Bivalent Inhibitors of Acetylcholinesterase, Part II]]
| |
| ****[[AChE_inhibitors_and_substrates|Inhibitors and Substrates of Acetylcholinesterase]]
| |
| ****[[ AChE_inhibitors_and_substrates_%28Part_II%29|Inhibitors and Substrates of Acetylcholinesterase, Part II]]
| |
| ****[[ AChE_inhibitors_and_substrates_%28Part_III%29|Inhibitors and Substrates of Acetylcholinesterase, Part III]]
| |
| ****Specific Examples:
| |
| *****[[1eve|Aricept Complexed with Acetylcholinesterase]]
| |
| *****[[2dfp|DFP (Aged) Complexed with Acetylcholinesterase]]
| |
| *****[[1ax9|Edrophonium Complexed with Acetylcholinesterase]] or [[2ack|Here]]
| |
| *****[[2j3q|Fluorophore Thioflavin T Complexed with Acetylcholinesterase]]
| |
| *****[[1dx6|Galanthamine Complexed with Acetylcholinesterase]]
| |
| *****[[1vot|Huperzine A Complexed with Acetylcholinesterase]]
| |
| *****[[1w6r|Iminium Galanthamine Derivative bound to Acetylcholinesterase]] or [[1w4l|Here]], or [[1w76|Here]].
| |
| *****[[1gqs|NAP Complexed with Acetylcholinesterase]]
| |
| *****[[1vxr|O-tthylmethylphosphonylated Acetylcholinesterase]]
| |
| *****[[2wfz|Soman Complexed with Acetylcholinesterase]] or [[2wg0|Here]], or [[2wg1|Here]], or [[1cfj|Here]], or [[1som|Here]].
| |
| *****[[1acj|Tacrine Complexed with Acetylcholinesterase]]
| |
| **** Bivalent Inhibitors
| |
| *****[[1u65|Anticancer Prodrug CPT-11 Complexed with Acetylcholinesterase]]
| |
| *****[[1eve|Aricept Complexed with Acetylcholinesterase]]
| |
| *****[[1w4l|Bis-Acting Galanthamine Derivative Complexed with Acetylcholinesterase]], or [[1w76|Here]], or [[1w6r|Here]]
| |
| *****[[2cmf|Bis-Tacrine Derivative Complexed with Acetylcholinesterase]] or [[2ckm|Here]] or [[1odc|Here]]
| |
| *****[[1acl|Bisquaternary Decamethonium Complexed with Acetylcholinesterase]]
| |
| *****[[1e3q|BW284C51 Complexed with Acetylcholinesterase]]
| |
| *****[[1zgb|Hupyridone Derivative Complexed with Acetylcholinesterase]], or [[1zgc|Here]], or [[1h22|Here]], or [[1h23|Here]]
| |
| *****[[1ut6|N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE Complexed with Acetylcholinesterase]]
| |
| *****[[1jjb|PEG-SH Complexed with Acetylcholinesterase]]
| |
| ***[[Gamma-Secratase]]
| |
| ***Glutamate Receptor
| |
| ****[[Glutamate receptor (GluA2)]]
| |
| ****[[Molecular_Playground/Glutamate_Receptor|Glutamate Receptor]]
| |
|
| |
|
| **Anemia | | **Anemia |